The objective of this study was to correlate the severity of erectile dysfunction (ED) with the total testosterone serum levels (TT) in a normal population. During a screening program for the early diagnosis of prostate cancer, 1071 men aged from 40 to 90 y, were invited to answer the questionnaire of the Simplified International Index of Erectile Function (IIEF-5) as a method to diagnose and classify ED. The IIEF-5 scores ranged from 1 to 25 and the ED was classified into five groups according to the scores: severe (1 -7), moderate (8 -11), mild -moderate (12 -16), mild (17 -21) and no . Besides the questionnaire, all subjects had their TT serum levels determined based on the blood sample obtained between 08:00 and 10:00. The analysis of the relationship between the different degrees of ED and TT levels was then studied. Of the 1071 men, 965 were included in the study (90.1%). Eighty-eight percent of these were Caucasian and 12% black. The mean age of the population was 60.7 y. The prevalence of all degrees of ED was 53.9%. The degree of ED was mild in 21.5%, mild to moderate in 14.3%, moderate in 6.3% and severe in 11.9%. The variation of TT serum concentrations was similar (P > 0.05) in the different age groups. Furthermore, the TT serum levels were not different for individuals with and without ED (P > 0.05) and similar concentrations of TT was observed in the different severity degrees of ED (P > 0.05). Only one (0.7%) man in the group of individual with maximal score had subnormal levels of TT. ED presented a clear association with the subjects' aging, but neither correlation between TT levels and ED, nor with its severity, could be demonstrated in the present study.
Introduction
Both hypogonadism and erectile dysfunction (ED) are common conditions in aging males. According to the data in the Massachusetts Male Aging Study (MMAS), 52% of the men aged from 40 to 70 presented some degree of ED. 1 Normal male sexual function depends on a complex interplay of psychological, neurological, vascular and endocrine factors. 1 -4 There is considerable controversy about the relative importance of each of these factors in the initiation and maintenance of an erection, especially the role of serum levels of testosterone. 2, 5 Several studies have documented that aging in men is associated with a decrease in sexual interest and activity, and particularly with an increased prevalence of erectile dysfunction. 1, 6 In the MMAS study a prevalence of 20% of hypogonadism for the men over 55 y of age was observed, when the TT levels below the normal rate for young, healthy subjects were considered. 1 The exact action of the androgens in sexual function is unclear but it is known that the actions of testosterone enhance libido and frequency of sexual acts, although, a causal relationship between altered levels of these and erectile dysfunction is inconclusive. 7 -9 However, we cannot attribute a causal relationship to these two conditions. Although there appears to be a relationship between the androgen serum levels and the libido and nocturnal erections, we do not have sufficient data to trace this same association with ED, nor with its severity. 1, 5, 6, 10 In this study, we seek to evaluate the relationship between the TT serum levels, with different degrees of ED severity in a population above 40 y of age.
Materials and methods
This is a cross-sectional study in which men above the age of 40 were invited to voluntarily answer the IIEF-5 questionnaire. The population studied was collected during Prostate Week, an event held annually to screen and provide an early diagnosis of prostate cancer in subjects above the age of 40 in the community. During the dissemination of this event through the media, at no time was there a reference to an evaluation of sexual function. The patients who did not wish to answer the questionnaire, who were being followed up in the UrologyAndrology Service at Santa Casa de Porto Alegre, used medication for ED, and subjects with major psychiatric disorders were excluded. Other subjects who had been submitted to any form of treatment for prostate cancer were also excluded.
The IIEF is a questionnaire with 15 questions, and it discusses the following parameters of sexual function: erectile function, orgasmic function, sexual desire, satisfaction with relations and overall satisfaction. 11, 12 In the present study, only the five questions which exclusively discuss erectile function were used. For each question a score of 0 -5 can be obtained, except for a question that varies from 1 to 5 points. Therefore, we can have a total score that ranges from 1 to 25 points. Individuals with scores above 21 points are considered normal (without ED), while those with scores equal to or below 21 points were considered as having ED. Furthermore, this questionnaire allows a grading of the ED severity, which was classified as follows: mild, 17 -21 points; mild to moderate, 12 -16 points; moderate, 8 -11 points; and severe, 1 -7 points. 11, 12 The population also was stratified according to the different age groups: 40 -49 y, 50 -59 y, 60 -69 y, 70 -79 y and 80 y or over. Total testosterone (radioimmunoassay techniques utilizing Immunochen TM coated tube Kits) was the only seric hormone measured. The blood samples were obtained between 08:00 and 10:00, (normal values ranged from 241 to 827 ng=dl).
The subjects with ED were subdivided according to the severity of the condition, and in each group the mean of the levels of TT was determined and the prevalence of men with subnormal and normal TT levels was evaluated proportionally as well as in the group of normal erectile function. The data obtained were evaluated statistically using Analysis of Variance (ANOVA) and the Student's t-test. Chi-square for proportional data. An alpha of 5% (P < 0.05) was considered for purposes of statistical significance.
Results
Of the 1071 men who came for prostatic evaluation, 965 (90.1%) were included in the study. The age of the population varied from 40 to 90 y, with a mean of 60.7 y. As regards color, 88% were Caucasian and the rest were black. Stratification according to the different age groups showed the following distribution: 40 -49 y, 11 (1.14%); 50 -59 y, 470 (48.7%); 60 -69 y, 334 (34.6%); 70 -79 y, 131 (13.6%); and 19 (1.96%) over the age of 80. Of the 965 men, 520 (53.9%) presented IIEF-5 scores lower than or equal to 21 points and were thus in the ED range (Table 1) .
In Table 2 are expressed the serum concentrations of TT for each group of men, according to the respective age groups. We did not observe a statistically significant difference (P > 0.05) between the mean androgen concentrations for the different age groups.
Classifying the individuals in the population according to the presence or not of ED, it was observed that the mean TT serum concentration, as well as the proportion of subjects with TT serum levels above and below the respective group mean, were not different (P > 0.05). These data are expressed in Table 3 . Normal values for total testosterone: 241 -827 ng=ml. ANOVA; P > 0.05. Normal values for total testosterone: 241 -827 ng=ml. ANOVA; P > 0.05.
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Equally, as can be seen as Table 3 , when we divided the groups according to severity of ED (mild, mild to moderate, moderate and severe) we did not observe a significant difference in the mean levels of TT. As is shown in Table 4 , when we divided the men according to the degree of ED and the frequency of the men with normal and subnormal levels of the androgen we could not to detect differences in the frequency (P > 0.05), that is, it was not possible to establish a relationship between the severity of the ED and the TT levels. Furthermore, as is shown in Table 4 , we observed that most individuals at the different degrees of ED presented androgen levels within normal limits.
On the other hand, when we exclusively analyzed the men whose IIEF-5 scores were 25 points (maximal score), only one (0.7%) of this select group presented TT levels in the range considered subnormal (see Table 5 ).
Discussion
The data in this study are not representative of a population selected in a randomized manner from a community and, thus, may not faithfully reflect the ED prevalence in this region and this was not the objective of the present study. The participants, however, sought medical care spontaneously to screen for prostate cancer. Moreover, the population studied did not consist only of the aged, and also did not include subjects who were being followed up for some andrological problem. The interest in researching the erectile function was only revealed at the time of the interview, and the patients were not previously aware of the objective of the study.
The questionnaire used in this study as a diagnostic tool is, currently, the only one recommended by the National Institute of Health (1993) to evaluate penile erectile function. 5 Furthermore, it allows a grading of ED severity, and not only the presence or absence of this condition. 11, 12 The direct relationship between ED and aging is well established, by data from several studies. 1, 5, 10 In the present study, this relationship was confirmed, showing a clear increase in the prevalence of ED, in to the older age groups. Thus, it was observed that between the age of 40 and 49, 36.4% mentioned some degree of ED, while this number rose to 79.4% in the 70 -79 age group.
There are many causes and explanations for this increased prevalence of ED with aging. Among them are vascular failure, hormonal disorders, neural interruptions, diabetes mellitus, psychogenic factors and the use of medicines that are more widely used in individuals of older age groups. 13 Moreover, histomorphometric studies of the corpus cavernosum reveal that major changes occur in this structure during life, when one compares the penile tissue characteristics of aged men with those of healthy young men. 11, 12 Among these histological changes, one of the most important is the progressive increase of collagen, at the same time as a reduction of the smooth muscles of the cavernous body. 14 -16 Furthermore, it is important to stress the biopharmacological changes which have repercussions, for instance, on the synthesis of nitric oxide and other neurotransmitters. 17, 18 The decline in serum androgen levels in aged men has also been extensively reported. Many terms are used to define this phenomenon, ranging from andropause, male climacteric, viropause, male menopause, penopause. These terms, however, are incorrect from the clinical -scientific standpoint. Currently, this hormonal decline has been called Partial Androgenic Decline of the Aging Male (PADAM, ADAM). 19 -21 The free testosterone levels diminish 1.2% a year, while the testosterone linked to albumin diminishes 1% a year. Moreover, the sexual hormone binding globulin levels (SHBG) increase by 1.2% a year, and the TT diminishes by 1% a year. 20 With this the final effect is a reduction in the bioavailable testosterone levels. The mechanisms of this decline have not been fully explained, and are probably multifactorial, involving the hypothalamic -hypophyseal -testicular axis. 22, 23 Testicular changes appear to contribute significantly to reducing the production of testosterone. Quantitative histological studies in men showed a significant reduction in the number and volume of the Leydig cells. 23 
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In the present study, however, there was no difference between the mean TT serum concentrations in the various age groups analyzed. However, we observed a tendency to lower androgen concentrations when men over 80 y of age were considered. As described by Vermeluen et al, 19 this decline in androgen serum levels presents a variation which is individually quite significant, that is, many aged men present levels equal to those found in young healthy subjects. The same author showed, in a cross-sectional study with healthy men, a progressive reduction in the mean TT serum and free levels, associated with an increase in the SHBG levels. These findings, however, were not demonstrated significantly from the statistical standpoint. Many authors believe that the bioavailable testosterone diminishes with aging, because of a proportional increase in the SHBG levels, which could not characterize the reduction of TT levels in laboratory work. Thus, TT may not faithfully represent the reduction of androgen levels. 22 Despite the fact that the decline in androgens, as well as the increased prevalence of ED, are agingrelated events, we cannot assign a direct cause and effect relationship to these two conditions. Morales et al, 25 in a recent meta-analysis, showed that the ED rates are much superior to those of hypogonadism in men between 40 and 60 y of age, and also in those over the age of 60. It is, therefore, concluded that other factors are involved in the erectile function, and that this condition cannot be attributed directly to the male hormonal profile. In the MMAS, of the 17 hormones measured, the only one that showed a statistically significant correlation with ED was sulphate dehydroepiandosterone (SDHEA). This relation can be explained in various ways, one of which is the fact that, probably the degree of decrease of this androgen is more significative with aging than the decrease of other androgens or the possibility of other actions of this androgen on sexual function.
Moreover, several other studies investigated the association between the androgens and sexual function and its most frequent conclusions are that the testosterone levels are positively correlated with sexual desire and with nocturnal erections, although not necessarily with erectile function. Furthermore, the results of studies that evaluated the effects of androgen hormonal replacement on sexual and erectile activity are not encouraging, and little or no beneficial effect can be expected when administering androgens to eugonadal men. 27 -30 Like the evidence shown in the literature, the data of this study do not allow a direct correlation between serum concentrations of TT and erective dysfunction to be established. This is initially observed when we compare the groups of men with and without ED, and we observe that the mean TT concentrations in these two groups were similar. Equally, when we analyzed the relationships of ED severity in its different groups, we did not obtain linearity or statistical significance. In other words, even in subjects with more severe degrees of ED, no larger proportion of hypogonadal subjects was found as compared to the other groups, with less severe degrees. These findings reinforce those observed in literature, where it becomes clear that the relationship between erectile function and androgens is very controversial. However, there is no doubt about the importance of testosterone in maintaining sexual function, which, in order to be complete, depends not only on erectile function, but also on behavioral and cognitive factors that make the subject engage in sexual activity.
This last aspect can be reinforced when we observe the hormone profile data in men whose IIEF-5 scores were maximal, that is, entirely normal erectile function in according to the IIEF-5 (score: 25 points). Attention is called to the fact that almost all individuals (99.3%) presented TT levels within normal limits. These aspects strongly suggest that androgen serum levels are a conditioning factor for normal sexual and erectile function.
Conclusion
This study corroborates the data from the literature as regards the strict relationship between ED and the aging process. Equally, it stresses that the frequency of this condition significantly increases with the aging. And finally, in the population studied, it did not prove possible to establish a statistically significant relationship between the TT levels and ED, or to the latter's severity.
